Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Indian Journal of Thoracic and Cardiovascular Surgery, published by SPRINGER INDIA, serves as a vital platform for the dissemination of innovative research and clinical advancements in the fields of cardiology, cardiovascular medicine, pulmonary, and respiratory medicine. With a rich history dating back to 1982 and spanning multiple years through to 2024, this journal aims to provide a comprehensive view of both theoretical and practical aspects of thoracic and cardiovascular surgery. Although it currently holds a Q3 quartile ranking across various relevant categories, researchers and practitioners can benefit from its insightful articles that contribute to ongoing discussions and advancements in these critical medical areas. The journal does not offer open access presently, yet it is accessible through major academic databases, providing valuable resources for professionals and students keen on enhancing their understanding and expertise. In a rapidly evolving field marked by technological advancements and novel research, the Indian Journal of Thoracic and Cardiovascular Surgery remains integral to fostering collaboration and education among its audience.

Cancer Research and Treatment is a premier academic journal published by the Korean Cancer Association that focuses on advancing scientific knowledge and clinical practices in the fields of cancer research and oncology. With an ISSN of 1598-2998 and an E-ISSN of 2005-9256, the journal showcases cutting-edge research articles, clinical trials, and comprehensive reviews that address the multifaceted challenges in cancer treatment and management. Published in South Korea, this journal has established itself as a critical resource, evidenced by its Q1 rank in Oncology and Q2 rank in Cancer Research, reflecting its influence and stature within the academic community. The impact of research disseminated through Cancer Research and Treatment is underscored by its significant percentile rankings in Scopus, with notable positions in both the pharmaceutical and biological sectors. This journal aims to bridge the gap between laboratory research and clinical application, providing a platform for researchers, healthcare professionals, and students to enhance their understanding of cancer-related innovations and therapeutic strategies. Readers will benefit from rich content that not only discusses the latest advancements but also engages with pressing global health issues related to cancer.

Kardiochirurgia i Torakochirurgia Polska - Polish Journal of Thoracic and Cardiovascular Surgery is an esteemed Open Access journal dedicated to the vibrant fields of thoracic and cardiovascular surgery. Established by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal has been providing a platform for innovative research and clinical practices since its inception. The journal, indexed with ISSN 1731-5530 and E-ISSN 1897-4252, plays a crucial role in disseminating knowledge within its domain, promoting advancements that impact patient care and outcomes. With a history of publication covering from 2008 to 2024, it features high-quality articles with contemporary insights in surgery and cardiology, ranked in Q4 and Q3 categories respectively as of 2023. With its presence in Scopus, where it holds notable ranks in both the surgery and cardiology disciplines, this journal is committed to fostering collaboration and innovation among researchers, professionals, and aspiring students alike, making it an indispensable resource for those engaged in the intricacies of thoracic and cardiovascular surgery.

General Thoracic and Cardiovascular Surgery is a pivotal academic journal dedicated to the rapidly evolving fields of thoracic and cardiovascular surgery. Published by SPRINGER JAPAN KK, this journal serves as a vital resource for clinicians, researchers, and medical professionals seeking insights into current practices, innovative techniques, and groundbreaking research. With an ISSN of 1863-6705 and an E-ISSN of 1863-6713, it has established a prominent presence in the academic community, demonstrated by its impressive ranking in the Q3 category for Cardiology and Cardiovascular Medicine and Surgery in 2023. The journal’s standards ensure high-quality, peer-reviewed articles that facilitate knowledge exchange and drive advancements in the field. Although it operates without open access, it remains accessible through library subscriptions and institutional affiliations. Covering a broad span of research from 2007 to 2024, General Thoracic and Cardiovascular Surgery is committed to enlightening its audience with findings that have substantial implications for clinical practices and patient outcomes.

Thoracic Surgery Clinics is a premier academic journal dedicated to advancing the field of thoracic surgery and related disciplines. Published by W B Saunders Co-Elsevier Inc, this journal has been a vital resource since its inception in 2004, presenting high-quality peer-reviewed articles that embrace the latest research, practice innovations, and clinical guidelines impacting thoracic and respiratory health. With a strong focus on multidisciplinary approaches, it caters to a diverse audience of researchers, medical professionals, and students. The journal currently ranks impressively in the Q2 category within Medicine (miscellaneous), Pulmonary and Respiratory Medicine, and Surgery, indicating its substantial influence and reach in the medical community. While not available as an open access publication, its concentrated aim is to enhance the knowledge base and clinical skills necessary for tackling complex thoracic surgical challenges. Join the ongoing discourse in this dynamic field through Thoracic Surgery Clinics, where cutting-edge research meets practical application.

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

Translational Lung Cancer Research is a leading journal dedicated to advancing the field of oncology, particularly focusing on groundbreaking discoveries in lung cancer treatment and management. Published by AME Publishing Company, this journal boasts an impressive Q1 classification in the 2023 Oncology category, reflecting its significant contribution to the scientific community, with an outstanding Scopus rank of #92 out of 404 in Medicine _ Oncology, placing it in the 77th percentile. With its commitment to open access, the journal fosters international collaboration and accessibility, making cutting-edge research available to a wide audience. The scope of Translational Lung Cancer Research encompasses clinical trials, experimental studies, and translational research that bridge the gap between laboratory findings and clinical applications. Researchers, professionals, and students seeking to keep abreast of the latest developments in lung cancer research will find invaluable insights within its pages. For further information, please contact at FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG.

Thoracic and Cardiovascular Surgeon Reports is a pivotal academic journal dedicated to the dissemination of innovative research and clinical practices in the fields of thoracic and cardiovascular surgery. Published by GEORG THIEME VERLAG KG, this journal has been an open-access publication since 2013, fostering a broader reach and enhancing visibility for authors and researchers globally. With its commitment to high-quality peer-reviewed articles, Thoracic and Cardiovascular Surgeon Reports serves as an essential platform for surgeons, clinicians, and scholars to share findings that advance medical knowledge, improve patient outcomes, and refine surgical techniques. The journal aims to bridge the gap between research and practical application, catering to an audience keen on staying updated with the latest in thoracic and cardiovascular interventions, making it a valuable resource in an ever-evolving medical landscape.

Experimental Hematology & Oncology is a premier journal published by BMC, dedicated to advancing knowledge in the fields of hematology, oncology, and cancer research. Since its inception in 2012, this Open Access journal has emerged as a vital resource for researchers and healthcare professionals, fostering the dissemination of high-quality research that enhances our understanding of blood disorders and malignancies. With impressive rankings in Quarters 1 of key categories including Cancer Research, Hematology, and Oncology, it holds significant prestige, evidenced by its Scopus rankings: #42/404 in Medicine (Oncology) and #17/137 in Medicine (Hematology). The journal aims to publish cutting-edge studies, reviews, and perspectives that contribute to the evolution of therapeutic strategies and innovative treatment modalities. Researchers and practitioners alike will find this journal indispensable for staying at the forefront of breakthroughs in hematological and oncological research.